Barbara Lener

Coordination and supervision of analytical activities within pharmaceutical QC laboratories focusing on the microbiological / chemical analysis of environmental monitoring samples, raw materials and pharmaceuticals.

QA responsibility for microbiological quality aspects of aseptic manufacture (bulk production and aseptic filling). Monitoring of compliance with internal and external standards and guidelines; close collaboration with various functions within the organization (QC, Production, Engineering, Registration, Compliance).

Development of a new diagnostic tool for progressive infectious diseases that allows the detection of HPV E7 Oncoprotein in cervical smears, as markers specific for persistent infections with bad prognosis. The project was partially funded by the European Commission as part of the 7th Framework Program ’PIPAVIR’.

Molekulare Zellbiologie; Dissertation: 'Role of NADPH- oxidase in endothelial cell senescence and oxidative stress'

Molekulare Mikrobiologie und Biochemie